Gil Blum
Stock Analyst at Needham
(3.14)
# 1,224
Out of 4,761 analysts
335
Total ratings
39.75%
Success rate
3.17%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FOLD Amicus Therapeutics | Reiterates: Hold | n/a | $9.07 | - | 6 | Feb 20, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $84 | $50.43 | +66.57% | 19 | Feb 12, 2025 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $11 | $10.35 | +6.28% | 21 | Feb 6, 2025 | |
| CELC Celcuity | Maintains: Buy | $23 → $29 | $13.13 | +120.87% | 13 | Feb 6, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $29 → $28 | $17.04 | +64.32% | 22 | Jan 29, 2025 | |
| SRPT Sarepta Therapeutics | Reiterates: Buy | $202 | $108.41 | +86.33% | 27 | Jan 27, 2025 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $41 | $19.61 | +109.08% | 12 | Jan 27, 2025 | |
| ABSI Absci | Initiates: Buy | $9 | $5.19 | +73.41% | 1 | Jan 22, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.95 | +412.82% | 26 | Jan 13, 2025 | |
| GERN Geron | Maintains: Buy | $6 → $7 | $2.63 | +166.16% | 20 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.87 | +143.90% | 15 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $29.87 | +137.70% | 11 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.62 | +1,200.81% | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.64 | +265.85% | 24 | Jan 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $2.19 | +402.28% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $105 | $65.61 | +60.04% | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $52 | $10.87 | +378.38% | 18 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.55 | - | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.29 | - | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.79 | +506.86% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $2.15 | +411.63% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.75 | +432.62% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.97 | +520.67% | 12 | Apr 12, 2024 |
Amicus Therapeutics
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.07
Upside: -
CRISPR Therapeutics AG
Feb 12, 2025
Reiterates: Buy
Price Target: $84
Current: $50.43
Upside: +66.57%
Recursion Pharmaceuticals
Feb 6, 2025
Reiterates: Buy
Price Target: $11
Current: $10.35
Upside: +6.28%
Celcuity
Feb 6, 2025
Maintains: Buy
Price Target: $23 → $29
Current: $13.13
Upside: +120.87%
Nurix Therapeutics
Jan 29, 2025
Maintains: Buy
Price Target: $29 → $28
Current: $17.04
Upside: +64.32%
Sarepta Therapeutics
Jan 27, 2025
Reiterates: Buy
Price Target: $202
Current: $108.41
Upside: +86.33%
Cartesian Therapeutics
Jan 27, 2025
Reiterates: Buy
Price Target: $41
Current: $19.61
Upside: +109.08%
Absci
Jan 22, 2025
Initiates: Buy
Price Target: $9
Current: $5.19
Upside: +73.41%
Autolus Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.95
Upside: +412.82%
Geron
Jan 13, 2025
Maintains: Buy
Price Target: $6 → $7
Current: $2.63
Upside: +166.16%
Jan 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.87
Upside: +143.90%
Jan 10, 2025
Reiterates: Buy
Price Target: $71
Current: $29.87
Upside: +137.70%
Jan 8, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $0.62
Upside: +1,200.81%
Jan 6, 2025
Reiterates: Buy
Price Target: $6
Current: $1.64
Upside: +265.85%
Dec 11, 2024
Reiterates: Buy
Price Target: $11
Current: $2.19
Upside: +402.28%
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $65.61
Upside: +60.04%
Nov 19, 2024
Reiterates: Buy
Price Target: $52
Current: $10.87
Upside: +378.38%
Nov 19, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.55
Upside: -
Nov 14, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.29
Upside: -
Nov 13, 2024
Reiterates: Buy
Price Target: $23
Current: $3.79
Upside: +506.86%
Nov 8, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $2.15
Upside: +411.63%
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.75
Upside: +432.62%
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $0.97
Upside: +520.67%